Vaxart Stock Is Rising For Several Days After News About Participation In The Congress

Vaxart is a company that manufactures vaccines that are consumed by ingesting medicine pills using an independent delivery platform. Vaxart’s vaccine can be transported without cooling in special containers. The shares of the biotech company have been growing for 4 consecutive days. During this period, the price increased by 16%. Investors hope that this will continue. In a pre-market session, the stock is trading at $7.89. Will the company be able to keep this pace until the end of the year to break its record for the highest price of $11.98 for 2021?

Oral Covid vaccine: can Vaxart overcome clinical trial obstacles?Vaxart, Inc. announced that the company’s vice president, Sean Tucker, will attend and speak at the World Vaccine & Immunotherapy Congress West Coast 2021, which will be held tomorrow. It’s part of an award-winning series of conferences and exhibitions that’s steadily rising to become the world’s largest and most established vaccination events. Vaxart’s CSO will discuss the company’s research program for an oral candidate for the COVID-19 vaccine in the form of tablets. The medicine that needs to be swallowed against coronavirus is the only oral vaccine of its kind against COVID-19, which has immunological potential, which is confirmed. And this is only one vaccine that has been conducting Phase 2 clinical trials since October 2021.

Richard McEntire

Finance and Entertainment Reporter Richard is a bottle of wine - the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.

Richard McEntire has 1844 posts and counting. See all posts by Richard McEntire